FDA Backs New Formulation of Noxafil

Published December 6, 2013

FDA backs new formulation of Noxafil
The approval from the Food and Drug Administration (FDA) for Noxafil delayed release covers the use of the drug to treat prophylaxis of invasive Aspergillus and Candida infections in patients who are aged 13 or over. … Dr Daniel Couriel, professor of … Read more on PMLiVE

With new HIV research, FDA may let gay men donate blood
A push by activists to ease the 30-year-old blanket ban on blood donations from gay and bisexual men faces a key test this week as a federal panel hears results of the latest research. The findings will be released amid growing pressure from … Read more on Washington Times

Protein in Prostate Biopsies Signals Increased Cancer Risk
The findings mean that potentially thousands of men a year — those with ERG-positive HGPIN biopsies — may benefit from increased surveillance and early treatment of prostate cancer, while those whose HGPIN biopsies come back ERG-negative may be … Read more on HealthCanal.com

Comedian, recovering addict Mark Lundholm brings 'PG-35' show, 'restrained …
20 at Western Michigan University's Dalton Center Recital Hall. The event is intended to create "better understanding of addiction and recovery in our community." It's put on by the Community Healing Center and the Drug Treatment Court Foundation of … Read more on Mlive Kalamazoo